Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
LGND —
LIGAND PHARMACEUTICALS INC
CUSIP: 53220K504 · Held by 2 superinvestors · Combined value: $3,246,899
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $2,451,481 | 12,966 | REDUCE | -7,146 |
| 2 | Ray Dalio | 0.0% | $795,418 | 4,207 | ADD | +2,919 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | ADD | +2,919 | +226.6% |
| Ken Griffin | REDUCE | -7,146 | -35.5% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | NEW BUY | +1,288 | New |
| Ken Griffin | REDUCE | -25,294 | -55.7% |
| Tweedy Browne | SOLD | -3,140 | Exit |
Who Owns LGND? Superinvestor Holdings
LIGAND PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $3 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Ray Dalio (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.